Discover
Automated NGS library preparation using the Biometra TRobot II
A key success factor in automated library preparation is the performance of the integrated thermal cycler.
October 28, 2026
3 Key Disease Applications for Cardiovascular Research
Intravital imaging offers a unique window into these dynamic processes, enabling researchers to visualize blood flow, thrombus formation, immune cell responses, and changes in the cardiac microenvironment in real time.
October 19, 2026
Biometra TAdvanced – Supported thermal cycler for 10x Genomics Single Cell and Spatial Applications
Perfect Partners to Unlock Cellular Insights. Understanding cell types and cell-cell interactions with major significance for health and disease.
September 7, 2026
Bioluminescence Distribution Of NPs In Rats’ Organs
Monitoring Nanoparticles distribution in rats' heart and liver with Alliance Chroma System
June 12, 2026
High-Throughput UVA-Based Thermal Shift Assays for Hydrophobic Proteins Using the qTOWER iris
This note demonstrates a UVA-based Thermal Shift Assay on the qTOWER iris, enabling sensitive detection of protein stability and expanding qPCR use to protein analysis.
April 23, 2026
Standardized Thawing and Sample Preparation of ARCTis Cryopreserved Human Tumor Cells
The standardized and automatic handling of cryopreserved biological samples plays an increasingly important role in today’s in vitro testing. This is due to the trend to develop more complex disease models to increase the data quality of studies.
March 30, 2026
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene
MOLECUBES β-CUBE and X-CUBE were used to investigate the ability of [18F]-TMP, a newly developed fluorine-18 probe, to image primary human chimeric antigen receptor (CAR) T cells expressing the PET reporter gene eDHFR.
October 12, 2026
Integrated IP-MS and Optoproteomics Reveal Dynamic Remodeling of Protein Interaction Networks
Combining IP-MS with Syncell optoproteomics reveals how the NLRP3 inflammasome dynamically reorganizes its protein interaction network and identifies a novel regulatory mechanism.
July 13, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression
mRNA vaccine efficacy is enhanced by preventing expression in hepatocytes rather than promoting it in dendritic cells. The findings highlight tissue-specific targeting as a potential strategy for improving vaccines and cancer immunotherapies.
June 5, 2026
Efficient DNA purification from cells: Automated workflows with sbeadex Lightning and CyBio FeliX
This application note presents a rapid, automated DNA purification workflow using the CyBio FeliX system with sbeadex Lightning technology, enabling high-quality results in just minutes while reducing hands-on time and increasing throughput.
April 16, 2026
Accelerating Antibody Discovery with the WOLF G2 Cell Sorter
Site-directed antibodies targeting driver mutations of the KRAS protein
March 16, 2026
Spatially Resolved Proteomic Profiling of Nuclear and Cytoplasmic Compartments using Microscoop®
Explore how Microscoop® enables spatially resolved nuclear and cytoplasmic proteomics, delivering reproducible, high-specificity subcellular protein profiling through microscopy-guided photolabeling and mass spectrometry.
October 5, 2026
More protein in less time: Automated native membrane protein purification with CyBio FeliX
Automated membrane protein purification with CyBio FeliX and NativeMP™ reduces processing time to under three hours while preserving protein integrity and ensuring high reproducibility.
June 29, 2026
Efficient DNA purification from cells: Automated workflows with sbeadex Lightning and CyBio FeliX
This application note presents a rapid, automated DNA purification workflow using the CyBio FeliX system with sbeadex Lightning technology, enabling high-quality results in just minutes while reducing hands-on time and increasing throughput.
May 6, 2026
PHF19 drives the formation of PRC2 clusters to enhance motility in TNBC cells
This study investigates the subnuclear organization of the Polycomb repressive complex 2 (PRC2) in triple-negative breast cancer (TNBC) cells, combining in situ proteomics, high-resolution imaging, and functional genomics.
April 14, 2026